Evidence map›Paper›PMID 36704879›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2023

Novel cell culture system for monitoring cells during continuous and variable negative-pressure wound therapy.

Toshifumi Yamashiro, Toshihiro Kushibiki, Yoshine Mayumi, Masato Tsuchiya, Miya Ishihara, Ryuichi Azuma

Open access · hybridAbstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Continuous negative-pressure wound therapy improves the survival rate of skin grafts and shortens the time required for skin graft survival.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  5. Article
  6. Novel cell culture system for monitoring cells during continuous and variable negative-pressure wound therapy.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Toshifumi YamashiroDepartment of Plastic and Reconstructive Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.ORCID https://orcid.org/0000-0001-7019-7740
Toshihiro KushibikiDepartment of Medical Engineering, National Defense Medical College, Tokorozawa, Saitama, Japan.
Yoshine MayumiDepartment of Medical Engineering, National Defense Medical College, Tokorozawa, Saitama, Japan.
Masato TsuchiyaDepartment of Plastic and Reconstructive Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Miya IshiharaDepartment of Medical Engineering, National Defense Medical College, Tokorozawa, Saitama, Japan.
Ryuichi AzumaDepartment of Plastic and Reconstructive Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
National Defense Medical College · JP

Funding

JSPS KAKENHI 20K12725
6 · The paper itself

Abstract

backgroundAlthough the clinical efficacy of negative-pressure wound therapy (NPWT) is well known, many of its molecular biological mechanisms remain unresolved, mainly due to the difficulty and paucity of relevant in vitro studies. We attempted to develop an in vitro cell culture system capable of real-time monitoring of cells during NPWT treatment. MATERIALS AND

methodsA novel negative-pressure cell culture system was developed by combining an inverted microscope, a stage-top incubator, a sealed metal chamber for cell culture, and an NPWT treatment device. Human keratinocytes, PSVK-1, were divided into ambient pressure (AP), continuous negative-pressure (NPc), and intermittent negative-pressure (NPi) groups and cultured for 24 h with scratch assay using our real-time monitoring system and device. Pressure inside the device, medium evaporation rate, and the residual wound area were compared across the groups.

resultsPressure in the device was maintained at almost the same value as set in all groups. Medium evaporation rate was significantly higher in the NPi group than in the other two groups; however, it had negligible effect on cell culture. Residual wound area after 9 h evaluated by the scratch assay was significantly smaller in the NPc and NPi groups than in the AP group.

conclusionWe developed a negative-pressure cell culture device that enables negative-pressure cell culture under conditions similar to those used in clinical practice and is able to monitor cells under NPWT. Further experiments using this device would provide high-quality molecular biological evidence for NPWT.

Indexed as

Negative-Pressure Wound TherapyBandagesCell Culture TechniquesHumansKeratinocytesWound Healingepithelial-to-mesenchymal transitionintermittent negative-pressure wound therapykeratinocytemicrodeformational wound therapynegative-pressure incubatortopical negative pressurevacuum-assisted closurewound healing

Identifiers

PMID36704879
PMCPMC9838773
OpenAlexW4312142478

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.